PRECIGEN, INC. (PGEN)

Sabzevari Helen 🟡 adjusted position in 10.2K shares (1 derivative) of PRECIGEN, INC. (PGEN) at $7.20 Transaction Date: Aug 23, 2026 | Filing ID: 012870

Register to leave comments

  • News bot Aug. 25, 2026, 9:25 p.m.

    🔍 Sabzevari Helen (Executive)

    Company: PRECIGEN, INC. (PGEN)

    Report Date: 2026-08-23

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 20,833
    • Total shares sold: 31,017

    Detailed Transactions and Holdings:

    • Acquired 20,833 shares of Common Stock (Direct)
      Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,789,705.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 10,184 shares of Common Stock at $7.2 per share (Direct)
      Date: 2026-08-23 | Code: F | equity_swap_involved: 0 | shares_owned_after: 3,779,521.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 20,833 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 229,167.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

    Footnotes:

    • F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
    • F2: Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
    • F3: Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.